Vascular dementia trial of Viagra-type drug nears closing stages

May 21, 2018, St. George's University of London
Credit: St. George's University of London

The Phase 2 trial (named PASTIS) is examining whether tadalafil – a Viagra-like drug that treats erectile dysfunction – can increase blood flow to the deep vessels within the brain.

Vascular is the second most prevalent cause of dementia, after Alzheimers' disease. Increasingly it is clear that changes to blood vessels within the brain could worsen dementia and speed cognitive decline.

The trial at St George's is being led by a Neuroscientist Dr. Atticus Hainsworth and funded by the Alzheimer's Society and a US charity, the Alzheimer's Drug Discovery Foundation. Consultant Neurologist Dr. Jeremy Isaacs of St George's Hospital is the clinical principal investigator.

The researchers recruited 55 older people with symptomatic small vessel disease. Over the course of two visits they were given either a tadalafil pill or a placebo. They had an MRI scan both before, and 3-5 hours after the dose was given.

Dr. Hainsworth explained: "All patients have now been scanned and we are analyzing the scans. After that we will unlock the trial and find out whether the drug did increase brain . While the exposure was very brief, we hope it will give us a clear picture of the difference the made, and allow us to build on this in future trials."

Dr. Hainsworth is also the lead of the Vascular Experimental Medicine group within Dementias Platform UK, a public-private partnership created by the Medical Research Council (MRC) to facilitate the discovery of new ways to understand, diagnose, and treat dementia.

He commented: "This links all the different dementia groups and researchers in the UK and is essential to ensure that we are all working together to make progress against this group of disorders, which affects 850,000 people in the UK."

Explore further: Drugs used for impotence could treat vascular dementia?

Related Stories

Drugs used for impotence could treat vascular dementia?

December 11, 2014
Scientists are to explore whether drugs usually used to treat erectile problems by expanding blood vessels could become the next major way to tackle the dementia epidemic.

Faults in the blood-brain barrier implicated in dementia

February 6, 2018
California based researchers have found that damage to cells known as pericytes, which surround small blood vessels in the brain, may trigger a chain of events that results in brain degeneration. The findings are published ...

Positive results from Alzheimer's drug in Phase 1 clinical trial extension

November 3, 2017
The pharmaceutical company Biogen has today announced the results of an extended phase 1b clinical trial of the potential Alzheimer's disease drug, aducanumab. Results from the extended early stage trial, were announced today ...

High blood pressure linked to vascular dementia

May 18, 2016
High blood pressure could significantly raise the risk of developing the second most common form of dementia, according to a new study from The George Institute for Global Health.

Tiny blood vessels in the brain could be the key in treating vascular dementia

June 22, 2017
Researchers from the University of Southampton are to study tiny channels embedded in the walls of blood vessels in the brain to assess their impact on dementia.

Alzheimer's drug targeting soluble amyloid falls short in a large clinical trial

January 25, 2018
A paper published today in the New England Journal of Medicine reports that solanezumab, a monoclonal antibody-based treatment for Alzheimer's disease developed by Eli Lilly that targets amyloid plaques, did not significantly ...

Recommended for you

Eye conditions provide new lens screening for Alzheimer's disease

August 8, 2018
Alzheimer's disease is difficult to diagnose as well as treat, but researchers now have a promising new screening tool using the window to the brain: the eye.

Potential indicator for the early detection of dementias

August 7, 2018
Researchers at the University of Basel have discovered a factor that could support the early detection of neurodegenerative diseases such as Alzheimer's or Parkinson's. This cytokine is induced by cellular stress reactions ...

pH imbalance in brain cells may contribute to Alzheimer's disease

August 2, 2018
Johns Hopkins Medicine scientists say they have found new evidence in lab-grown mouse brain cells, called astrocytes, that one root of Alzheimer's disease may be a simple imbalance in acid-alkaline—or pH—chemistry inside ...

Newly characterized molecule offers possibilities for novel Alzheimer's treatments

August 2, 2018
Alzheimer's disease is an increasingly prevalent, neurodegenerative condition that erodes memory and other cognitive functions. Treatments for this complex disease have been elusive, although researchers have previously uncovered ...

Alzheimer's drug may stop disease if used before symptoms develop

August 1, 2018
About 50 percent of people who reach the age of 85 will develop Alzheimer's disease. Most will die within about five years of exhibiting the hallmark symptoms of the disease – severe memory loss and a precipitous decline ...

Microfluidic system incorporates neuroinflammation into 'Alzheimer's in a dish' model

July 30, 2018
Building on their development of the first culture system to replicate fully the pathology behind Alzheimer's disease, a Massachusetts General Hospital (MGH) research team has now produced a system that includes neuroinflammation, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.